| Glasdegib studied in …STUDIED_INderived17 of 17show fewer |
|---|
| → studied in | NCT04231851Phase 2 · active not recruiting CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia · 17 trials list this drug (1 active) | — | — | Acute Myeloid Leukemia, Myelodysplasia-Related | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03784014Phase 3 · completed Molecular Profiling of Advanced Soft-tissue Sarcomas · 17 trials list this drug (1 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03226418Phase 2 · completed Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia · 17 trials list this drug (1 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Post Cytotoxic Therapy,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02038777Phase 1 · completed A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies · 17 trials list this drug (1 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00953758Phase 1 · completed A Study Of PF-04449913 In Select Hematologic Malignancies · 17 trials list this drug (1 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03466450Phase 1/Phase 2 · completed Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma · 17 trials list this drug (1 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01286467Phase 1 · completed A Study Of PF-04449913 Administered Alone In Select Solid Tumors · 17 trials list this drug (1 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04842604Phase 3 · completed Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML · 17 trials list this drug (1 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03390296Phase 1/Phase 2 · completed OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia · 17 trials list this drug (1 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04230564withdrawn Acute Myeloid Leukemia Real World Treatment Patterns · 17 trials list this drug (1 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03416179Phase 3 · completed A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia · 17 trials list this drug (1 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04093505Phase 3 · terminated Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia) · 17 trials list this drug (1 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04655391Phase 1 · withdrawn Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation · 17 trials list this drug (1 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01841333Phase 2 · completed PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant · 17 trials list this drug (1 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04051996Phase 2 · terminated GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia · 17 trials list this drug (1 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01842646Phase 2 · completed Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS) · 17 trials list this drug (1 active) | — | — | Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01546038Phase 2 · completed A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome · 17 trials list this drug (1 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |